The DOI matches its Crossref record.
Metals, Oxidative Stress, and Hepatic Fibrogenesis
Open accessAbstract
Progressive fibrosis of organs, such as the liver, the kidney, or the lung, is the basis of mechanistically related disorders that are major causes of morbidity and mortality. As keloids and hypertrophic dermal scarring may result in disfigurement and disability, scarring in the liver leads to disruption of normal lobular architecture, nodular regeneration, and loss of function. Hepatic fibrosis is now regarded as a common response of the liver to a chronic insult which, regardless of its nature (e.g., viral infection, alcohol abuse, metal overload), leads to cell damage and/or necrosis followed by excessive deposition of extracellular matrix components.' The cellular and molecular mechanisms underlying the formation of the hepatic scar are likely to be common to different types of chronic liver injury. In fact, all the disorders mentioned above share the common feature of a progressive and inappropriate accumulation of connective tissue, dominated by collagen. Early events such as accumulation of collagen fibrils in the space of Disse are reversible. Basically, enhanced collagen expression can be regarded as an "acute-phase" response of mesenchymal cells, the major effectors of liver fibrogenesis, as a result of complex interconnected pathways involving autocrine and paracrine signals elicited in hepatic resident and nonresident cells. Overall, this expresses a defensive response of the liver to the inciting insult, and the healing process usually leads to recovery and restoration of normal liver architecture and function. In conditions where the primary tissue-damaging cause persists, the response becomes chronic, thus perpetuating the stimulus to fibrogenesis. The accompanying alterations of vascularization and reorganization of replicating hepatocytes in nodules direct the progression to the nonreversible stage of the "cirrhotic" liver. As examples of liver toxicity, metal overload diseases may share with other types of liver diseases common pathways to liver fibrosis. Thus, wherever there is
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Nelson, J. E., Wilson, L., Brunt, E. M., Yeh, M. M., Kleiner, D. E., Unalp-Arida, A., & Kowdley, K. V. (2011) · Hepatology · doi:10.1002/hep.24038 · Cited by 356
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
Liver fibrosis: from the bench to clinical targets
Pinzani, M., & Rombouts, K. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.01.003 · Cited by 336
Metadata
- Authors
- Pietrangelo, A.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1996
- Volume
- 16
- Issue
- 01
- Pages
- 13-30
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2052691143
- Cited by
- 166
- References
- 0
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metals, Oxidative Stress, and Hepatic Fibrogenesis. https://app.cochat.ai/papers/10.1055/s-2007-1007215
- The paper
- Pietrangelo, A. (1996). Metals, Oxidative Stress, and Hepatic Fibrogenesis. Seminars in Liver Disease. https://doi.org/10.1055/s-2007-1007215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.